{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:37:54Z","timestamp":1788784674680,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020917","name":"Economic Research Institute for ASEAN and East Asia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Access to essential in vitro diagnostics is limited in many low- and middle-income countries (LMICs). To address this, the World Health Organization introduced the Model List of Essential In Vitro Diagnostics (EDL) in 2018, encouraging member states to develop National Essential Diagnostics Lists (NEDLs). To date, five LMICs\u2014Burkina Faso, Ethiopia, India, Nepal, and Nigeria\u2014have developed NEDLs. However, gaps remain in the objectives of NEDL development, which may undermine their effective use. In this study, we aimed to analyze the objectives of NEDL development through a literature review, elicit potential pathways for achieving these objectives, and develop an assessment framework for defining NEDL objectives and pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed the WHO EDL and NEDL documents and other relevant materials, aligning the objectives mentioned in these documents with a logic model. A provisional assessment framework was then designed and applied to examine stakeholder perspectives on NEDL objectives, which were obtained through key informant interviews in four Association of Southeast Asian Nations (ASEAN) countries\u2014Cambodia, Indonesia, Lao PDR, and the Philippines\u2014where NEDL initiatives are still in their early stages. Based on these findings, a revised assessment framework was developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The literature review yielded a provisional assessment framework comprising six domains: procurement, supply chain, laboratory equipment maintenance, quality assurance, regulatory work, and benefit packages. An analysis of stakeholder perspectives in the four ASEAN countries identified potential pathways for achieving the NEDL objectives across these six domains and other aspects. This process resulted in a new seven-domain assessment framework, incorporating key modifications to the provisional framework: \u201cbenefit packages\u201d was replaced with \u201chealth financing\u201d, and \u201cservice delivery platform\u201d was added as the seventh domain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The newly developed assessment framework can support high-level officials in initiating NEDL development and promoting its effective use. It can also guide health ministries in selecting NEDL leads and technical committee members and help identify intermediary outcomes for monitoring NEDL operationalization. Although empirical evidence on NEDL outcomes remains limited owing to its early global implementation stage, this study provides valuable insights to support the future development and deployment of NEDLs and strengthen diagnostic systems in LMICs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41182-025-00839-w","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:57:43Z","timestamp":1762426663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identifying pathways to achieve diverse objectives of the National Essential Diagnostics List: developing an assessment framework based on field studies in Cambodia, Indonesia, Lao PDR, and the Philippines"],"prefix":"10.1186","volume":"53","author":[{"given":"Shogo","family":"Kanamori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Egami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Miyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio F. dela Resma","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataro","family":"Norizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Uechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Koto-Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"839_CR1","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/s0140-6736(21)00673-5","volume":"398","author":"KA Fleming","year":"2021","unstructured":"Fleming KA, Horton S, Wilson ML, Atun R, DeStigter K, Flanigan J, et al. The Lancet Commission on diagnostics: transforming access to diagnostics. Lancet. 2021;398:1997\u20132050. https:\/\/doi.org\/10.1016\/s0140-6736(21)00673-5.","journal-title":"Lancet"},{"key":"839_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005357","author":"NE Ntinginya","year":"2021","unstructured":"Ntinginya NE, Kuchaka D, Orina F, Mwebaza I, Liyoyo A, Miheso B, et al. Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country setting. BMJ Glob Health. 2021. https:\/\/doi.org\/10.1136\/bmjgh-2021-005357.","journal-title":"BMJ Glob Health"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12875-024-02406-4","volume":"25","author":"M Ansu-Mensah","year":"2024","unstructured":"Ansu-Mensah M, Bawontuo V, Kuupiel D, Ginindza TG. Sustainable solutions to barriers of point-of-care diagnostic testing services in health facilities without laboratories in the Bono region, Ghana: a qualitative study. BMC Prim Care. 2024;25:179. https:\/\/doi.org\/10.1186\/s12875-024-02406-4.","journal-title":"BMC Prim Care"},{"key":"839_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12913-015-1114-7","volume":"15","author":"CF Anticona Huaynate","year":"2015","unstructured":"Anticona Huaynate CF, Pajuelo Traveza\u00f1o MJ, Correa M, Mayta Malpartida H, Oberhelman R, Murphy LL, et al. Diagnostics barriers and innovations in rural areas: insights from junior medical doctors on the frontlines of rural care in Peru. BMC Health Serv Res. 2015;15:454. https:\/\/doi.org\/10.1186\/s12913-015-1114-7.","journal-title":"BMC Health Serv Res"},{"key":"839_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s41043-025-00788-4","volume":"44","author":"E Malla","year":"2025","unstructured":"Malla E, Shahi S, Forsberg B. Barriers and facilitators to tuberculosis service access for patients in Bajhang, Nepal: a qualitative study based on focus groups with patients, screening camp visitors, community volunteers and medical doctors. J Health Popul Nutr. 2025;44:46. https:\/\/doi.org\/10.1186\/s41043-025-00788-4.","journal-title":"J Health Popul Nutr"},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1021\/acsinfecdis.4c00466","volume":"10","author":"TKA Teibo","year":"2024","unstructured":"Teibo TKA, Andrade RLP, Rosa RJ, de Abreu PD, Olayemi OA, Alves YM, et al. Barriers that interfere with access to tuberculosis diagnosis and treatment across countries globally: a systematic review. ACS Infect Dis. 2024;10:2600\u201314. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00466.","journal-title":"ACS Infect Dis"},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1080\/17441692.2020.1801791","volume":"15","author":"M Stevenson","year":"2020","unstructured":"Stevenson M. A situation analysis of the state of supply of in vitro diagnostics in low-income countries. Glob Public Health. 2020;15:1836\u201346. https:\/\/doi.org\/10.1080\/17441692.2020.1801791.","journal-title":"Glob Public Health"},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/diagnostics5020200","volume":"5","author":"R McNerney","year":"2015","unstructured":"McNerney R. Diagnostics for developing countries. Diagnostics (Basel). 2015;5:200\u20139. https:\/\/doi.org\/10.3390\/diagnostics5020200.","journal-title":"Diagnostics (Basel)"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.31662\/jmaj.2022-0089","volume":"6","author":"D Inagaki","year":"2023","unstructured":"Inagaki D, Nakahara S, Chung UI, Shimaoka M, Shoji K. Need for improvements in medical device management in low- and middle-income countries: applying learnings from Japan\u2019s experience. JMA J. 2023;6:188\u201391. https:\/\/doi.org\/10.31662\/jmaj.2022-0089.","journal-title":"JMA J"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12885-018-5169-9","volume":"19","author":"S Cassim","year":"2019","unstructured":"Cassim S, Chepulis L, Keenan R, Kidd J, Firth M, Lawrenson R. Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review. BMC Cancer. 2019;19:25. https:\/\/doi.org\/10.1186\/s12885-018-5169-9.","journal-title":"BMC Cancer"},{"key":"839_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/hex.14142","volume":"27","author":"C Vincent","year":"2024","unstructured":"Vincent C, Fenge LA, Porter S, Holland S. Exploring whether and how people experiencing high deprivation access diagnostic services: a qualitative systematic review. Health Expect. 2024;27:e14142. https:\/\/doi.org\/10.1111\/hex.14142.","journal-title":"Health Expect"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.11604\/pamj.2018.29.73.14399","volume":"29","author":"T Oystacher","year":"2018","unstructured":"Oystacher T, Blasco D, He E, Huang D, Schear R, McGoldrick D, et al. Understanding stigma as a barrier to accessing cancer treatment in South Africa: implications for public health campaigns. Pan Afr Med J. 2018;29:73. https:\/\/doi.org\/10.11604\/pamj.2018.29.73.14399.","journal-title":"Pan Afr Med J"},{"key":"839_CR13","unstructured":"World Health Organization. The selection and use of essential in vitro diagnostics: report of the fourth meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2022 (including the fourth WHO model list of essential in vitro diagnostics). Geneva: World Health Organization; 2023. https:\/\/iris.who.int\/bitstream\/handle\/10665\/373322\/9789240081093-eng.pdf?sequence=1 [accessed July 25, 2025]."},{"key":"839_CR14","unstructured":"World Health Organization. Seventy-Sixth World Health Assembly Agenda Item 13.1 (WHA76.5): Strengthening diagnostic capacity. Geneva: World Health Organization, 2023."},{"key":"839_CR15","unstructured":"World Health Organization. Selection of essential in vitro diagnostics at country level using the WHO Model List of Essential In Vitro Diagnostics to develop and update a national list of essential in vitro diagnostics. Geneva: World Health Organization; 2021. https:\/\/iris.who.int\/bitstream\/handle\/10665\/343385\/9789240030923-eng.pdf?sequence=1 [accessed July 25, 2025]."},{"key":"839_CR16","volume-title":"Liste nationale des tests de Diagnostic In vitro essentiels par niveau de soins [National List of Essential In Vitro Diagnostic Tests by Level of Care]","author":"Minist\u00e8re de la Sant\u00e9 et de l'Hygi\u00e8ne Publique","year":"2023","unstructured":"Minist\u00e8re de la Sant\u00e9 et de l\u2019Hygi\u00e8ne Publique. Liste nationale des tests de Diagnostic In vitro essentiels par niveau de soins [National List of Essential In Vitro Diagnostic Tests by Level of Care]. Ouagadougou: Minist\u00e8re de la Sant\u00e9 et de l\u2019Hygi\u00e8ne Publique; 2023."},{"key":"839_CR17","volume-title":"Ethiopian essential health laboratory diagnostics list","author":"Ethiopian Public Health Institute","year":"2025","unstructured":"Ethiopian Public Health Institute. Ethiopian essential health laboratory diagnostics list. Addis Ababa: Ethiopian Public Health Institute; 2025."},{"key":"839_CR18","unstructured":"Walia K, Vijay S. National Essential Diagnostics List, 2025. New Delhi: Indian Council of Medical Research, 2025."},{"key":"839_CR19","volume-title":"National Essential In-vitro Diagnostic List","author":"Ministry of Health and Population","year":"2023","unstructured":"Ministry of Health and Population. National Essential In-vitro Diagnostic List. Kathmandu: Ministry of Health and Population; 2023."},{"key":"839_CR20","unstructured":"Federal Ministry of Health. Nigeria National Essential Diagnostics List. Abuja: Federal Ministry of Health, 2022."},{"key":"839_CR21","unstructured":"Economic Research Institute for ASEAN and East Asia. 2024 Annual Report. Jakarta: ERIA; 2025. https:\/\/www.eria.org\/uploads\/AR_2024-24_Jun_2025-web.pdf [accessed August 1, 2025]."},{"key":"839_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001893","volume":"3","author":"W Koster","year":"2023","unstructured":"Koster W, Mutegi EM, Ocen F, Odhiambo CO, Waweru MM, Ndione AG, et al. Contexts for developing of national essential diagnostics lists. Lessons from a mixed-methods study of existing documents, stakeholders and decision making on tier-specific essential in-vitro diagnostics in African countries. PLOS Glob Public Health. 2023;3:e0001893. https:\/\/doi.org\/10.1371\/journal.pgph.0001893.","journal-title":"PLOS Glob Public Health"},{"key":"839_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0734371x16682815","volume":"38","author":"M van der Hoek","year":"2018","unstructured":"van der Hoek M, Groeneveld S, Kuipers B. Goal setting in teams: goal clarity and team performance in the public sector. Rev Public Pers Adm. 2018;38:472\u201393. https:\/\/doi.org\/10.1177\/0734371x16682815.","journal-title":"Rev Public Pers Adm"},{"key":"839_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/s0140-6736(03)13375-2","volume":"361","author":"R Laing","year":"2003","unstructured":"Laing R, Waning B, Gray A, Ford N, t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361:1723\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(03)13375-2.","journal-title":"Lancet"},{"key":"839_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087576","volume":"9","author":"YT Bazargani","year":"2014","unstructured":"Bazargani YT, Ewen M, de Boer A, Leufkens HG, Mantel-Teeuwisse AK. Essential medicines are more available than other medicines around the globe. PLoS ONE. 2014;9:e87576. https:\/\/doi.org\/10.1371\/journal.pone.0087576.","journal-title":"PLoS ONE"},{"key":"839_CR26","doi-asserted-by":"publisher","first-page":"1355239","DOI":"10.3389\/fpubh.2024.1355239","volume":"12","author":"X Xiong","year":"2024","unstructured":"Xiong X, Huo Z, Zhou S, Bai G, He S, Zhou Y, et al. Short- and long-term impacts of the National Essential Medicines Policy on drug availability, price, and usage in a deprived rural county in southwestern China: an interrupted time series analysis across 8 years. Front Public Health. 2024;12:1355239. https:\/\/doi.org\/10.3389\/fpubh.2024.1355239.","journal-title":"Front Public Health"},{"key":"839_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40545-020-00234-2","volume":"13","author":"P Brhlikova","year":"2020","unstructured":"Brhlikova P, Maigetter K, Murison J, Agaba AG, Tusiimire J, Pollock AM. Registration and local production of essential medicines in Uganda. J Pharm Policy Pract. 2020;13:31. https:\/\/doi.org\/10.1186\/s40545-020-00234-2.","journal-title":"J Pharm Policy Pract"},{"key":"839_CR28","unstructured":"United Way of Greater Rochester. A Guide to Developing an Outcome Logic Model. 2015. https:\/\/www.yourunitedway.org\/wp-content\/uploads\/2015\/12\/UWGRP-Guide-to-Outcomes-and-Logic-Models-6-8-15.pdf [accessed August 29, 2025]."},{"key":"839_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2471\/blt.20.268037","volume":"99","author":"S Vijay","year":"2021","unstructured":"Vijay S, Gangakhedkar RR, Shekhar C, Walia K. Introducing a national essential diagnostics list in India. Bull World Health Organ. 2021;99:236\u20138. https:\/\/doi.org\/10.2471\/blt.20.268037.","journal-title":"Bull World Health Organ"},{"key":"839_CR30","volume-title":"Impact of a National Essential Diagnostics List (Presentation at the Regional Consultative Meeting on National Essential Diagnostics Lists for ASEAN Member States, 6 June 2024)","author":"S Himley","year":"2024","unstructured":"Himley S. Impact of a National Essential Diagnostics List (Presentation at the Regional Consultative Meeting on National Essential Diagnostics Lists for ASEAN Member States, 6 June 2024). Bangkok: World Health Organization; 2024."},{"key":"839_CR31","unstructured":"Ministry of Health. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07\/MENKES\/1801\/2024 Tentang Standar Laboratorium Kesehatan Masyarakat [Decree of the Minister of Health of the Republic of Indonesia Number HK.01.07\/MENKES\/1801\/2024 Concerning Public Health Laboratory Standards]. Jakarta: Republic of Indonesia, 2024."},{"key":"839_CR32","unstructured":"Department of Health. FDA Memorandum Circular No. 2014-005 Updated List of Medical Devices required to be registered prior to sale, distribution and use. Manila: Republic of the Philippines, 2014."},{"key":"839_CR33","unstructured":"Philippine Health Insurance Corporation. PhilHealth Circular No. 2020-0021 Accreditation of Health Care Providers for PhilHealth Konsultasyong Sulit at Tama (PhilHealth Konsulta) Package. Manila: Republic of the Philippines, 2020."},{"key":"839_CR34","unstructured":"Department of Health. Administrative Order No. 2021-0037 New Rules and Regulations Governing the Regulation of Clinical Laboratories in the Philippines. Manila: Republic of the Philippines, 2021."},{"key":"839_CR35","unstructured":"Department of Health. Administrative Order No. 2007\u20130027 Revised Rules and Regulations Governing the Licensure and Regulation of Clinical Laboratories in the Philippines. Manila: Republic of the Philippines, 2007."}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00839-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00839-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00839-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:57:49Z","timestamp":1762426669000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00839-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00839-w","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable because this study did not involve the use of human participants, data, or tissues.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable because this article does not contain personal data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}